Building Trust and Awareness to Increase AZ Native Nation Participation in COVID-19 Vaccines
Abstract
:1. Introduction
2. Materials and Methods
2.1. Tribal Partners
2.2. Project Goals and Objectives
2.3. Recruitment and Incentives
2.4. Consensus Panels and Education Materials Development
2.5. Survey Development and REDCap® Integration
2.6. CHR Training and Support
2.7. Data Collection and Analysis
3. Results
3.1. Demographics
3.2. Trusted COVID-19 Health Messengers
3.3. Vaccine Confidence
3.4. Acceptability and Satisfaction with Intervention
3.5. CHR Questionnaire and Project Reflection
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Strassle, P.D.; Stewart, A.L.; Quintero, S.M.; Bonilla, J.; Alhomsi, A.; Santana-Ufret, V.; Maldonado, A.I.; Forde, A.T.; Nápoles, A.M. COVID-19-Related Discrimination Among Racial/Ethnic Minorities and Other Marginalized Communities in the United States. Am. J. Public Health 2022, 112, 453–466. [Google Scholar] [CrossRef] [PubMed]
- Sequist, T.D. The Disproportionate Impact of COVID-19 on Communities of Color. NEJM Catal. 2022, 1, 1–9. [Google Scholar] [CrossRef]
- Hatcher, S.M.; Agnew-Brune, C.; Anderson, M.; Zambrano, L.D.; Rose, C.E.; Jim, M.A.; Baugher, A.; Liu, G.S.; Patel, S.V.; Evans, M.E.; et al. COVID-19 Among American Indian and Alaska Native Persons—23 States, January 31–July 3, 2020. MMWR Morb. Mortal Wkly. Rep. 2020, 69, 1166–1169. [Google Scholar] [CrossRef] [PubMed]
- Centers for Disease Control and Prevention. Vaccine Information for Adults. Available online: https://www.cdc.gov/vaccines/adults/reasons-to-vaccinate.html (accessed on 8 August 2022).
- Marshall, G.S. Vaccine Hesitancy, History, and Human Nature: The 2018 Stanley A. Plotkin Lecture. J. Pediatr. Infect. Dis. Soc. 2019, 8, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Dube, E.; Ward, J.K.; Verger, P.; MacDonald, N.E. Vaccine Hesitancy, Acceptance, and Anti-Vaccination: Trends and Future Prospects for Public Health. Annu. Rev. Public Health 2021, 42, 175–191. [Google Scholar] [CrossRef] [PubMed]
- Baden, L.R.; El Sahly, H.M.; Essink, B.; Kotloff, K.; Frey, S.; Novak, R.; Diemert, D.; Spector, S.A.; Rouphael, N.; Creech, C.B. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 2021, 384, 403–416. [Google Scholar] [CrossRef] [PubMed]
- Bordeaux, S.J.; Baca, A.W.; Begay, R.L.; Gachupin, F.C.; Caporaso, J.G.; Herbst-Kralovetz, M.M.; Lee, N.R. Designing inclusive HPV cancer vaccines and increasing uptake among native americans—A cultural perspective review. Curr. Oncol. 2021, 28, 3705–3716. [Google Scholar] [CrossRef] [PubMed]
- Arizona Department of Education. Tribal Nations’ COVID-19 Mandates. 2021. Available online: https://www.azed.gov/oie/stay-home-orders-tracker (accessed on 1 April 2021).
- Goodluck, K. COVID-19 Impacts Every Corner of the Navajo Nation. High Country News 2020. Available online: https://www.hcn.org/issues/52.6/covid-19-impacts-every-corner-of-the-navajo-nation (accessed on 9 August 2022).
- Silverman, H.; Toropin, K.; Sidner, S.; Perrot, L. Navajo Nation Surpasses New York State for the Highest COVID-19 Infection Rate in the US. 2020. Available online: https://cbs58.com/news/navajo-nation-surpasses-new-york-state-for-the-highest-covid-19-infection-rate-in-the-us (accessed on 9 August 2022).
- National Institutes of Health. NIH launches Clinical Trials Network to Test COVID-19 Vaccines and Other Prevention Tools. 2020. Available online: https://www.nih.gov/news-events/news-releases/nih-launches-clinical-trials-network-test-covid-19-vaccines-other-prevention-tools (accessed on 10 August 2022).
- Khubchandani, J.; Sharma, S.; Price, J.H.; Wiblishauser, M.J.; Sharma, M.; Webb, F.J. COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment. J. Community Health 2021, 46, 270–277. [Google Scholar] [CrossRef] [PubMed]
- Indian Health Service. Community Health Representative. Available online: https://www.ihs.gov/chr/ (accessed on 27 September 2022).
- Sabo, S.; O’Meara, L.; Neel, A. Community Health Representative Workforce Assessment (Phase II): A Report to the Arizona Advisory Council on Indian Health Care in Collaboration with the Arizona Community Health Representative Coalition; Center for Health Equity Research, Northern Arizona University: Flagstaff, AZ, USA, 2020. [Google Scholar]
- Wallerstein, N.B.; Duran, B. Using community-based participatory research to address health disparities. Health Promot. Pract. 2006, 7, 312–323. [Google Scholar] [CrossRef] [PubMed]
- Northern Arizona University. Tribal Consultation. 2020. Available online: https://nau.edu/wp-content/uploads/sites/26/Tribal-Consultation.pdf (accessed on 1 October 2022).
- Wightman, P.; McCue, K.; Sabo, S.; Annorbah, R.; Jiménez, D.; Pilling, V.; Butler, M.; Celaya, M.F.; Rumann, S. Community health worker intervention improves early childhood vaccination rates: Results from a propensity-score matching evaluation. BMC Public Health 2022, 22, 1854. [Google Scholar] [CrossRef] [PubMed]
- Sharma, N.; Harris, E.; Lloyd, J.; Mistry, S.K.; Harris, M. Community health workers involvement in preventative care in primary healthcare: A systematic scoping review. BMJ Open 2019, 9, e031666. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yellow Horse, A.J.; Yang, T.-C.; Huyser, K.R. Structural inequalities established the architecture for COVID-19 pandemic among native Americans in Arizona: A geographically weighted regression perspective. J. Racial Ethn. Health Disparities 2022, 9, 165–175. [Google Scholar] [CrossRef]
- Foxworth, R.; Redvers, N.; Moreno, M.A.; Lopez-Carmen, V.A.; Sanchez, G.R.; Shultz, J.M. COVID-19 Vaccination in American Indians and Alaska Natives—Lessons from Effective Community Responses. N. Engl. J. Med. 2021, 385, 2403–2406. [Google Scholar] [CrossRef]
- National Academies of Sciences. COVID-19 Vaccines: Studying Historical Successes (and Failures) for Equity-Centered Approaches to Vaccinating Indigenous Communities, Undocumented Immigrants, and Communities of Color: Proceedings of a Workshop—In Brief; National Academies of Sciences: Washington, DC, USA, 2022. [Google Scholar] [CrossRef]
(%) of Total n | |
---|---|
Age (years; n = 161) | |
18–20 | 5.0 |
21–30 | 18.0 |
31–40 | 19.9 |
41–50 | 20.5 |
51–60 | 16.1 |
61–70 | 12.4 |
71–80 | 5.6 |
81–90 | 2.5 |
Mean age: 46 y.o. | |
Gender (n = 164) | |
Man | 37.2 |
Woman | 60.4 |
Nonbinary, genderqueer, or genderfluid | 0.6 |
Prefer not to answer | 1.8 |
Race (n = 165) 1 | |
American Indian or Alaska Native | 92.1 |
White | 3.6 |
Black or African American | 0.6 |
Prefer not to answer | 3.0 |
Other | 2.4 |
Hispanic or Latino (n = 162) | |
Yes | 10.5 |
No | 82.7 |
Prefer not to answer | 6.8 |
No. of household members (n = 165) | |
1–2 | 33.3 |
3–5 | 50.9 |
6 or more | 15.8 |
No. of household members who have had COVID-19 (n = 165) | |
0 | 53.3 |
1–2 | 27.9 |
3 or more | 18.8 |
No. of household members vaccinated against COVID-19 (n = 165) | |
0 | 23.6 |
1–2 | 48.5 |
3 or more | 27.9 |
Question: How Much Do You Trust Each of These Sources to Provide Correct Information about COVID 19 Vaccines? | (%) of Total n |
---|---|
Your doctor or healthcare provider (n = 162) | |
Not at all | 7.4 |
Neutral | 29.0 |
A little | 25.9 |
A great deal | 37.7 |
Your close friends and members of your family (n = 163) | |
Not at all | 19.6 |
Neutral | 41.7 |
A little | 16.0 |
A great deal | 22.7 |
People you go to work or class with or other people you know (n = 146) | |
Not at all | 19.9 |
Neutral | 44.5 |
A little | 17.8 |
A great deal | 17.8 |
Community Health Worker/Community Health Representative (n = 136) | |
Not at all | 7.4 |
Neutral | 33.1 |
A little | 23.5 |
A great deal | 36.0 |
News on the radio, TV, online, or in newspapers (n = 133) | |
Not at all | 33.8 |
Neutral | 39.1 |
A little | 18.0 |
A great deal | 9.0 |
Your contacts on social media (n = 127) | |
Not at all | 48.8 |
Neutral | 29.1 |
A little | 13.4 |
A great deal | 8.7 |
Your faith leader (n = 128) | |
Not at all | 20.3 |
Neutral | 37.5 |
A little | 18.0 |
A great deal | 24.2 |
The U.S. government (n = 127) | |
Not at all | 34.6 |
Neutral | 52.0 |
A little | 11.0 |
A great deal | 2.4 |
The Arizona state government (n = 126) | |
Not at all | 31.7 |
Neutral | 50.0 |
A little | 15.1 |
A great deal | 3.2 |
Local tribal government (n = 126) | |
Not at all | 21.4 |
Neutral | 48.4 |
A little | 20.6 |
A great deal | 9.5 |
Neighboring tribal government (n = 126) | |
Not at all | 19.8 |
Neutral | 57.1 |
A little | 16.7 |
A great deal | 6.3 |
(%) of Total n at Baseline | (%) of Total n at Follow-Up | |
---|---|---|
Vaccine Status | ||
Vaccinated against COVID-19? (n = 165) | ||
Yes | 65.5 | 67.3 |
Which vaccine did you get? (n = 109; n = 111) 1 | ||
1 dose Moderna or Pfizer vaccine | 2.8 | 16.2 |
2 doses Moderna or Pfizer vaccine | 96.3 | 79.3 |
1 dose Johnson & Johnson vaccine | 0.0 | 3.6 |
Not sure | 0.9 | 0.9 |
Vaccine Confidence | ||
Why would you get a COVID-19 vaccine? (n = 165) | ||
I want to keep my family safe | 73.9 | 50.3 |
I want to keep my community safe | 50.9 | 29.1 |
I want to keep myself safe | 61.2 | 47.9 |
I have an ongoing health problem, like asthma or diabetes | 23.6 | 15.2 |
My doctor told me to get a COVID-19 vaccine | 13.3 | 6.7 |
I don’t want to get really sick from COVID-19 | 31.5 | 26.1 |
I want to feel safe around other people | 35.8 | 23.6 |
I believe life won’t go back to normal until most people get a COVID-19 vaccine | 28.5 | 14.5 |
Other 2 | 9.1 | 6.1 |
Why would you NOT get a COVID-19 vaccine (n = 165) | ||
I was fully vaccinated against COVID-19 before the education session | x | 13.9 |
I’m allergic to vaccines | 2.4 | 0.6 |
I have other allergies | 6.1 | 1.8 |
I don’t like needles | 13.3 | 2.4 |
I’m not concerned about getting really sick from COVID-19 | 4.2 | 0.6 |
I’m concerned about side effects from the vaccine | 38.8 | 7.9 |
I don’t think vaccines work very well | 4.2 | 0.6 |
I don’t trust that the vaccine will be safe | 20.6 | 8.5 |
I don’t believe the COVID-19 pandemic is as bad as some people say it is | 1.8 | 0.6 |
I don’t want to pay for it | 3.6 | 0.0 |
I don’t know enough about how well a COVID-19 vaccine works | 34.5 | 3.6 |
Other 3 | 15.8 | 6.7 |
Paired Samples Test | |||||
Paired Differences | Significance | ||||
Knowledge/Ability to Do the following before and after Intervention | Mean | Mean | Std. Deviation | One-Sided p | |
Pair 1 (n = 162) | Explain how the COVID-19 vaccine works 1 | 2.97 | −0.383 | 1.492 | <0.001 |
Explain how the COVID-19 vaccine works 2 | 3.35 | ||||
Pair 2 (n = 163) | Explain the side effects of the COVID-19 vaccine 1 | 3.07 | −0.282 | 1.455 | 0.007 |
Explain the side effects of the COVID-19 vaccine 2 | 3.36 | ||||
Pair 3 (n = 137) | Arrange for a COVID-19 vaccine for yourself or family member 1 | 3.62 | −0.307 | 1.292 | 0.003 |
Arrange for a COVID-19 vaccine for yourself or family member 2 | 3.93 |
(%) of Total n | |
---|---|
Have you used the COVID-19 education session handouts or information to talk to a family member or friend about getting the COVID-19 vaccine since our last visit? (n = 163) | |
Yes | 55.8 |
No | 44.2 |
Overall, I am satisfied with the COVID-19 vaccine education session. (n = 161) | |
Strongly disagree | 2.5 |
Disagree | 4.3 |
Neutral | 21.7 |
Agree | 52.2 |
Strongly agree | 19.3 |
The education session felt relevant to my community and culture. (n = 163) | |
Strongly disagree | 3.7 |
Disagree | 1.8 |
Neutral | 30.1 |
Agree | 45.4 |
Strongly agree | 19.0 |
I trust the information provided in the COVID-19 vaccine education session. (n = 152) | |
Strongly disagree | 2.6 |
Disagree | 5.3 |
Neutral | 25.7 |
Agree | 44.1 |
Strongly agree | 22.4 |
I trust the educator providing this information. (n = 139) | |
Strongly disagree | 2.9 |
Disagree | 2.2 |
Neutral | 20.9 |
Agree | 51.1 |
Strongly agree | 23.0 |
The information shared was easy to understand. (n = 133) | |
Strongly disagree | 3.0 |
Disagree | 0.0 |
Neutral | 19.5 |
Agree | 57.9 |
Strongly agree | 19.5 |
The education session gave new information about COVID-19 that I did not previously know. (n = 131) | |
Strongly disagree | 3.1 |
Disagree | 9.9 |
Neutral | 27.5 |
Agree | 42.7 |
Strongly agree | 16.8 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sears, G.; Tutt, M.; Sabo, S.; Lee, N.; Teufel-Shone, N.; Baca, A.; Bennett, M.; Nashio, J.T.N.; Flores, F.; Baldwin, J. Building Trust and Awareness to Increase AZ Native Nation Participation in COVID-19 Vaccines. Int. J. Environ. Res. Public Health 2023, 20, 31. https://doi.org/10.3390/ijerph20010031
Sears G, Tutt M, Sabo S, Lee N, Teufel-Shone N, Baca A, Bennett M, Nashio JTN, Flores F, Baldwin J. Building Trust and Awareness to Increase AZ Native Nation Participation in COVID-19 Vaccines. International Journal of Environmental Research and Public Health. 2023; 20(1):31. https://doi.org/10.3390/ijerph20010031
Chicago/Turabian StyleSears, Grant, Marissa Tutt, Samantha Sabo, Naomi Lee, Nicolette Teufel-Shone, Anthony Baca, Marianne Bennett, J. T. Neva Nashio, Fernando Flores, and Julie Baldwin. 2023. "Building Trust and Awareness to Increase AZ Native Nation Participation in COVID-19 Vaccines" International Journal of Environmental Research and Public Health 20, no. 1: 31. https://doi.org/10.3390/ijerph20010031
APA StyleSears, G., Tutt, M., Sabo, S., Lee, N., Teufel-Shone, N., Baca, A., Bennett, M., Nashio, J. T. N., Flores, F., & Baldwin, J. (2023). Building Trust and Awareness to Increase AZ Native Nation Participation in COVID-19 Vaccines. International Journal of Environmental Research and Public Health, 20(1), 31. https://doi.org/10.3390/ijerph20010031